Thyrocare Technologies dips 7% as PharmaEasy offers to acquire 66% stake

Docon Technologies, along with API Holdings, the parent company of unicorn PharmEasy, also made an open offer for acquisition of additional 26% stake in Thyrocare at a price of Rs 1,300 per share

Shares of Thyrocare Technologies dipped 7 per cent to Rs 1,351 on the BSE in Monday's intra-day after Docon Technologies, along with API Holdings, the parent company of unicorn PharmEasy, an online medical platform, will acquire 66.1 per cent equity stake in diagnostic chain firm for Rs 4,546 crore. They also made an open offer for acquisition of additional 26 per cent stake in Thyrocare at a price of Rs 1,300 per share for Rs 1,788.16 crore.

This would be the first ever acquisition of a listed company, by an Indian unicorn, the companies said in a joint statement.